News & Announcements

The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

The Medicines Patent Pool and AbbVie Sign Licensing Agreement to Increase Access to Crucial HIV Treatments Throughout Africa

The Medicines Patent Pool welcomes USAID’s selection of two South African organisations to address HIV/AIDS

Upcoming events

Recent Highlights

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine

New agreements for TAF signed with Lupin and Micro Labs

View our sub-licensees section

Ensuring new medicines reach those in most need

Read MPP’s Executive Director, Greg Perry and Head of Policy, Esteban Burrone’s comment published in the latest issue of The Lancet HIV

ARV forcasts presented at IAS 2015

Forecasted demand for current and new ARV medicines in low- and middle-income countries, 2014-2025